Skip to content

Optical Imaging For Assessment of Foot Perfusion

Optical Imaging For Assessment of Foot Perfusion

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03144050
Enrollment
400
Registered
2017-05-08
Start date
2017-04-14
Completion date
2018-07-31
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Ulcer Foot

Brief summary

This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities and to understand how it might be used in a podiatry clinic.

Detailed description

This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities and to understand how it might be used in a podiatry clinic. SFDI is a non-contact optical imaging technology that measures tissue functional (blood volume, tissue oxygen saturation) and structural information (scattering index) across a large field of view. Our hypothesis is that SFDI parameters can eventually become a quantitative tool to assess foot health and identify patients at risk for ulcer formation. This phase of the study is designed to correlate SFDI outputs to current clinical risk categories

Interventions

DEVICESFDI Imaging

Imaging with SFDI device

Sponsors

Kaiser Permanente
CollaboratorOTHER
Modulated Imaging Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\-

Exclusion criteria

* Pregnant/lactating women * Rheumatoid arthritis

Design outcomes

Primary

MeasureTime frameDescription
Clinical risk categoryimmediaterisk assessment based on clinical signs

Secondary

MeasureTime frameDescription
Ulcer incidence1 yearUlcer formation

Countries

United States

Contacts

Primary ContactKalvin Yu, MD
kalvin.c.yu@kp.org6264053906

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026